Carbimazole BP-USP-ep

Carbimazole BP-USP-ep Specification

Solubility
Clear, colourless solution

Storage
Dry Place

Molecular Weight
186.23

Melting Point
28.5-31C

Loss on Drying
0.5%

Molecular Formula
C7H10N2O2S

Medicine Name
Carbimazole

Chemical Name
ethyl 3-methyl-2-sulfanylideneimidazole-1-carboxylate

CAS No
22232-54-8

Type
Pharmaceutical Intermediates

Grade
Medicine Grade

Usage
Pharmaceutical

Purity(%)
98.0 - 102.0 % (dried substance)

Appearance
White or pale yellow crystalline powder

Physical Form
Powder

Carbimazole BP-USP-ep Trade Information

Minimum Order Quantity
50 Kilograms

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

About Carbimazole BP-USP-ep

It is a member of the class ofimidazoles that is methimazole in which the nitrogen bearing a hydrogen is converted into its ethoxycarbonyl derivative. A prodrugfor methimazol, carbimazole is used for the treatment of hyperthyroidism.It has a role as a prodrug and an antithyroid drug.

High Purity and Pharmaceutical Grade

Carbimazole BP-USP-ep stands out due to its exceptional purity, ranging from 98.0 to 102.0% as a dried substance. This high purity makes it a dependable choice for pharmaceutical applications, specifically for developing treatments targeting thyroid disorders. The medicine-grade classification guarantees that it meets stringent industry standards.

Storage and Handling Recommendations

To maintain its efficacy, Carbimazole should be stored in a dry place away from moisture and direct sunlight. Its crystalline structure and low loss on drying ( 0.5%) help preserve stability, but adherence to proper storage is crucial for ensuring longevity and optimal results in pharmaceutical manufacturing.

Applications in Pharmaceutical Industry

Carbimazole is primarily utilized as an intermediate in synthesizing thyroid medications. Its clear solubility profile and controlled melting point facilitate its integration into various pharmaceutical processes. As an essential ingredient, it supports reliable medicinal formulations to help manage hyperthyroidism across global markets.

FAQs of Carbimazole BP-USP-ep:

Q: How is Carbimazole BP-USP-ep typically used in the pharmaceutical industry?

A: Carbimazole BP-USP-ep serves as a key intermediate in producing medications designed to treat hyperthyroidism by reducing the amount of hormone produced by the thyroid gland.

Q: What are the storage requirements for Carbimazole BP-USP-ep powder?

A: It should be stored in a dry place, protected from moisture and direct sunlight, to ensure product integrity and prolonged shelf life.

Q: When should Carbimazole BP-USP-ep be utilized during pharmaceutical manufacturing?

A: This compound is usually incorporated during the intermediate stages of medicine production, particularly in crafting formulations for thyroid-related treatments.

Q: Where can Carbimazole BP-USP-ep be sourced?

A: It can be obtained directly from manufacturers, exporters, and suppliers based in India who specialize in pharmaceutical-grade intermediates.

Q: What is the benefit of using a high-purity Carbimazole for medicinal purposes?

A: High-purity Carbimazole ensures consistent therapeutic effects, reduces risk of impurities, and enhances safety and efficacy in the final pharmaceutical product.

Q: What is the process for integrating Carbimazole BP-USP-ep into medication development?

A: Typically, it is dissolved into a clear, colorless solution and carefully measured according to pharmaceutical protocols before being incorporated into medicinal formulations.

Q: What is the appearance and solubility of Carbimazole BP-USP-ep?

A: Carbimazole BP-USP-ep appears as a white or pale yellow crystalline powder and is highly soluble, producing a clear and colorless solution upon dissolution.

Tell us about your requirement